Tue. 5 Mar 2024, 4:30pm ET
Benzinga
Earnings, Earnings Beats, News
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.07) by 34.58 percent. This is a 70.83 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $1.31 million which beat the analyst consensus estimate of $1.06 million by 23.87 percent. This is a 769.54 percent increase over sales of $151.00 thousand the same period last year.